Mannkind is a California-based biotechnology company that develops and commercializes novel therapeutics to treat diabetes and pulmonary arterial hypertension... Read more
MannKind CEO: Michael Castagna

CEO

Michael Castagna

CEO Approval Rating

49/100

Annual Revenue
$285.5M
Employees
400
Funding
$227.3M
Acquisitions
3
Investments
1

MannKind Competitors

1ViaCyte
2Selecta
3Peloton Therapeutics
4Tarveda
5Semma Therapeutics
6Blueprint
7Sitka Biopharma
8Cristal Therapeutics
9AVEO
10Dauntless Pharmaceuticals

Trending Companies